Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

[11C]PBR28 MR-PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder.

Zürcher NR, Loggia ML, Mullett JE, Tseng C, Bhanot A, Richey L, Hightower BG, Wu C, Parmar AJ, Butterfield RI, Dubois JM, Chonde DB, Izquierdo-Garcia D, Wey HY, Catana C, Hadjikhani N, McDougle CJ, Hooker JM.

Mol Psychiatry. 2020 Feb 19. doi: 10.1038/s41380-020-0682-z. [Epub ahead of print]

PMID:
32076115
2.

Mobile device applications and treatment of autism spectrum disorder: a systematic review and meta-analysis of effectiveness.

Moon SJ, Hwang J, Hill HS, Kervin R, Birtwell KB, Torous J, McDougle CJ, Kim JW.

Arch Dis Child. 2019 Dec 17. pii: archdischild-2019-318258. doi: 10.1136/archdischild-2019-318258. [Epub ahead of print]

PMID:
31848147
3.

Maternal and early postnatal immune activation produce sex-specific effects on autism-like behaviors and neuroimmune function in mice.

Carlezon WA Jr, Kim W, Missig G, Finger BC, Landino SM, Alexander AJ, Mokler EL, Robbins JO, Li Y, Bolshakov VY, McDougle CJ, Kim KS.

Sci Rep. 2019 Nov 15;9(1):16928. doi: 10.1038/s41598-019-53294-z.

4.

Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series.

Thom RP, Keary CJ, Waxler JL, Pober BR, McDougle CJ.

J Autism Dev Disord. 2020 Feb;50(2):676-682. doi: 10.1007/s10803-019-04301-9.

PMID:
31724120
5.

Comparison of Services for Autism Spectrum Disorder in Massachusetts with Those in Seoul.

Kim JW, Kim HW, Moon DS, Lim YS, McDougle CJ, Howe YJ.

J Korean Med Sci. 2019 Nov 11;34(43):e288. doi: 10.3346/jkms.2019.34.e288.

6.

Sleep and EEG biomarkers as avenues toward new treatment approaches in Angelman syndrome.

McDougle CJ, Keary CJ.

Neuropsychopharmacology. 2020 Jan;45(1):238-239. doi: 10.1038/s41386-019-0517-2. No abstract available.

PMID:
31501527
7.

Challenges in the Medical Care of Patients With Autism Spectrum Disorder: The Role of the Consultation-Liaison Psychiatrist.

Thom RP, McDougle CJ, Hazen EP.

Psychosomatics. 2019 Sep - Oct;60(5):435-443. doi: 10.1016/j.psym.2019.04.003. Epub 2019 Apr 28.

PMID:
31174865
8.

Accuracy of self-reported history of autoimmune disease: A pilot study.

O'Rourke JA, Ravichandran C, Howe YJ, Mullett JE, Keary CJ, Golas SB, Hureau AR, McCormick M, Chung J, Rose NR, McDougle CJ.

PLoS One. 2019 May 29;14(5):e0216526. doi: 10.1371/journal.pone.0216526. eCollection 2019.

9.

Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

Thom RP, Keary CJ, Palumbo ML, Ravichandran CT, Mullett JE, Hazen EP, Neumeyer AM, McDougle CJ.

Psychopharmacology (Berl). 2019 Oct;236(10):3045-3061. doi: 10.1007/s00213-019-05280-6. Epub 2019 May 28. Review.

PMID:
31139876
10.

Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD).

Missig G, McDougle CJ, Carlezon WA Jr.

Neuropsychopharmacology. 2020 Jan;45(1):90-103. doi: 10.1038/s41386-019-0409-5. Epub 2019 May 6. Review.

PMID:
31060044
11.

A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder.

Smith CJ, Bhanot A, Norman E, Mullett JE, Bilbo SD, McDougle CJ, Zürcher NR, Hooker JM.

J Autism Dev Disord. 2019 Jul;49(7):3036-3044. doi: 10.1007/s10803-019-04010-3.

PMID:
31004246
12.

Women and Autism Spectrum Disorder: Diagnosis and Implications for Treatment of Adolescents and Adults.

Green RM, Travers AM, Howe Y, McDougle CJ.

Curr Psychiatry Rep. 2019 Mar 9;21(4):22. doi: 10.1007/s11920-019-1006-3. Review.

PMID:
30852705
13.

Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series.

Balaj K, Nowinski L, Walsh B, Mullett J, Palumbo ML, Thibert RL, McDougle CJ, Keary CJ.

Psychiatr Genet. 2019 Apr;29(2):51-56. doi: 10.1097/YPG.0000000000000218.

PMID:
30681431
14.

Another Step Toward Defining an Immune-Mediated Subtype of Autism Spectrum Disorder.

McDougle CJ.

JAMA Netw Open. 2018 Jun 1;1(2):e180280. doi: 10.1001/jamanetworkopen.2018.0280. No abstract available.

15.

Sex-dependent neurobiological features of prenatal immune activation via TLR7.

Missig G, Robbins JO, Mokler EL, McCullough KM, Bilbo SD, McDougle CJ, Carlezon WA Jr.

Mol Psychiatry. 2019 Jan 4. doi: 10.1038/s41380-018-0346-4. [Epub ahead of print]

PMID:
30610201
16.

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.

Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L.

Compr Psychiatry. 2019 Jan;88:57-64. doi: 10.1016/j.comppsych.2018.10.012. Epub 2018 Nov 6.

17.

Pharmacotherapy of Down syndrome.

Palumbo ML, McDougle CJ.

Expert Opin Pharmacother. 2018 Dec;19(17):1875-1889. doi: 10.1080/14656566.2018.1529167. Epub 2018 Oct 10. Review.

PMID:
30257591
18.

A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.

Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ.

Neuropsychopharmacology. 2018 Jul;43(8):1772-1778. doi: 10.1038/s41386-018-0039-3. Epub 2018 Feb 27.

19.

Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC-Amygdala Circuits.

Li Y, Missig G, Finger BC, Landino SM, Alexander AJ, Mokler EL, Robbins JO, Manasian Y, Kim W, Kim KS, McDougle CJ, Carlezon WA Jr, Bolshakov VY.

J Neurosci. 2018 Mar 28;38(13):3358-3372. doi: 10.1523/JNEUROSCI.3642-17.2018. Epub 2018 Feb 28.

20.

Nutrition and Bone Density in Boys with Autism Spectrum Disorder.

Neumeyer AM, Cano Sokoloff N, McDonnell EI, Macklin EA, McDougle CJ, Holmes TM, Hubbard JL, Misra M.

J Acad Nutr Diet. 2018 May;118(5):865-877. doi: 10.1016/j.jand.2017.11.006. Epub 2018 Mar 2.

21.

Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series.

Valdes F, Keary CJ, Mullett JE, Palumbo ML, Waxler JL, Pober BR, McDougle CJ.

J Autism Dev Disord. 2018 Mar;48(3):947-952. doi: 10.1007/s10803-017-3384-x.

PMID:
29164439
22.

Perinatal Immune Activation Produces Persistent Sleep Alterations and Epileptiform Activity in Male Mice.

Missig G, Mokler EL, Robbins JO, Alexander AJ, McDougle CJ, Carlezon WA Jr.

Neuropsychopharmacology. 2018 Feb;43(3):482-491. doi: 10.1038/npp.2017.243. Epub 2017 Oct 6.

23.

Overweight and obese status in children with autism spectrum disorder and disruptive behavior.

Criado KK, Sharp WG, McCracken CE, De Vinck-Baroody O, Dong L, Aman MG, McDougle CJ, McCracken JT, Eugene Arnold L, Weitzman C, Leventhal JM, Vitiello B, Scahill L.

Autism. 2018 May;22(4):450-459. doi: 10.1177/1362361316683888. Epub 2017 Mar 22.

24.

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Wink LK, Minshawi NF, Shaffer RC, Plawecki MH, Posey DJ, Horn PS, Adams R, Pedapati EV, Schaefer TL, McDougle CJ, Swiezy NB, Erickson CA.

Mol Autism. 2017 Jan 25;8:2. doi: 10.1186/s13229-017-0116-1. eCollection 2017.

25.

Bone microarchitecture in adolescent boys with autism spectrum disorder.

Neumeyer AM, Cano Sokoloff N, McDonnell E, Macklin EA, McDougle CJ, Misra M.

Bone. 2017 Apr;97:139-146. doi: 10.1016/j.bone.2017.01.009. Epub 2017 Jan 11.

26.

Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.

Scahill L, Bearss K, Sarhangian R, McDougle CJ, Arnold LE, Aman MG, McCracken JT, Tierney E, Gillespie S, Postorino V, Vitiello B.

J Child Adolesc Psychopharmacol. 2017 Mar;27(2):125-131. doi: 10.1089/cap.2016.0107. Epub 2016 Nov 28.

27.

Bone Accrual in Males with Autism Spectrum Disorder.

Neumeyer AM, Cano Sokoloff N, McDonnell E, Macklin EA, McDougle CJ, Misra M.

J Pediatr. 2017 Feb;181:195-201.e6. doi: 10.1016/j.jpeds.2016.10.080. Epub 2016 Nov 22.

28.

Communication Deficits and the Motor System: Exploring Patterns of Associations in Autism Spectrum Disorder (ASD).

Mody M, Shui AM, Nowinski LA, Golas SB, Ferrone C, O'Rourke JA, McDougle CJ.

J Autism Dev Disord. 2017 Jan;47(1):155-162. doi: 10.1007/s10803-016-2934-y.

PMID:
27785593
29.

No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.

Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L.

J Child Adolesc Psychopharmacol. 2016 Dec;26(10):900-908. Epub 2016 Oct 11.

30.

Atypical Antipsychotic-Induced Weight Gain in Children and Adolescents: Sometimes Less Is More.

McDougle CJ.

JAMA Psychiatry. 2016 Sep 1;73(9):899-901. doi: 10.1001/jamapsychiatry.2016.1213. No abstract available.

PMID:
27556412
31.

Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research.

Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AFT, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA Jr, Carter CS, Cook EH Jr, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA Jr, Zubieta JK.

Biol Psychiatry. 2016 Jul 15;80(2):84-86. doi: 10.1016/j.biopsych.2016.05.004. No abstract available.

32.

Rapid clinical deterioration in an individual with Down syndrome.

Jacobs J, Schwartz A, McDougle CJ, Skotko BG.

Am J Med Genet A. 2016 Jul;170(7):1899-902. doi: 10.1002/ajmg.a.37674. Epub 2016 May 5.

PMID:
27149638
33.

Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.

Scahill L, Jeon S, Boorin SJ, McDougle CJ, Aman MG, Dziura J, McCracken JT, Caprio S, Arnold LE, Nicol G, Deng Y, Challa SA, Vitiello B.

J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):415-23. doi: 10.1016/j.jaac.2016.02.016. Epub 2016 Mar 7.

34.

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA.

Mol Autism. 2016 Apr 21;7:26. doi: 10.1186/s13229-016-0088-6. eCollection 2016.

35.

IQSEC2 and X-linked syndromal intellectual disability.

Alexander-Bloch AF, McDougle CJ, Ullman Z, Sweetser DA.

Psychiatr Genet. 2016 Jun;26(3):101-8. doi: 10.1097/YPG.0000000000000128.

PMID:
27010919
36.

Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study.

Rengit AC, McKowen JW, O'Brien J, Howe YJ, McDougle CJ.

J Autism Dev Disord. 2016 Jul;46(7):2514-9. doi: 10.1007/s10803-016-2763-z. Review.

PMID:
26944591
37.

A Pilot Study of Autism-Specific Care Plans During Hospital Admission.

Broder-Fingert S, Shui A, Ferrone C, Iannuzzi D, Cheng ER, Giauque A, Connors S, McDougle CJ, Donelan K, Neumeyer A, Kuhlthau K.

Pediatrics. 2016 Feb;137 Suppl 2:S196-204. doi: 10.1542/peds.2015-2851R.

38.

Psychopharmacological interventions in autism spectrum disorder.

Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ.

Expert Opin Pharmacother. 2016;17(7):937-52. doi: 10.1517/14656566.2016.1154536. Epub 2016 Mar 7. Review.

PMID:
26891879
39.

Attention Bias to Emotional Faces Varies by IQ and Anxiety in Williams Syndrome.

McGrath LM, Oates JM, Dai YG, Dodd HF, Waxler J, Clements CC, Weill S, Hoffnagle A, Anderson E, MacRae R, Mullett J, McDougle CJ, Pober BR, Smoller JW.

J Autism Dev Disord. 2016 Jun;46(6):2174-2185. doi: 10.1007/s10803-016-2748-y.

40.

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders.

Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, Hurwitz S, McDougle CJ, Swiezy NB, Erickson CA.

Mol Autism. 2016 Jan 14;7:2. doi: 10.1186/s13229-015-0062-8. eCollection 2016.

41.

Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.

Wink LK, Pedapati EV, Horn PS, McDougle CJ, Erickson CA.

J Child Adolesc Psychopharmacol. 2017 Feb;27(1):91-94. doi: 10.1089/cap.2015.0123. Epub 2015 Oct 14.

42.

Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.

Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, Sanders R, Minjarez M, Cowen J, Mullett J, Page C, Ward D, Deng Y, Loo S, Dziura J, McDougle CJ; Research Units on Pediatric Psychopharmacology Autism Network.

Am J Psychiatry. 2015 Dec;172(12):1197-206. doi: 10.1176/appi.ajp.2015.15010055. Epub 2015 Aug 28.

43.

Iron homeostasis during risperidone treatment in children and adolescents.

Calarge CA, Ziegler EE, Del Castillo N, Aman M, McDougle CJ, Scahill L, McCracken JT, Arnold LE.

J Clin Psychiatry. 2015 Nov;76(11):1500-5. doi: 10.4088/JCP.14m09258.

44.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

45.

Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder.

Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L.

Autism. 2016 Jul;20(5):528-37. doi: 10.1177/1362361315593941. Epub 2015 Jul 17.

PMID:
26187059
46.

A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.

Dominick K, Wink LK, McDougle CJ, Erickson CA.

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):397-401. doi: 10.1089/cap.2014.0111.

47.

Neural targets in the study and treatment of social cognition in autism spectrum disorder.

Vahabzadeh A, Landino SM, Finger BC, Carlezon WA Jr, McDougle CJ.

Handb Exp Pharmacol. 2015;228:309-34. doi: 10.1007/978-3-319-16522-6_11. Review.

PMID:
25977088
48.

Topiramate for weight loss in two young adult women with autism spectrum disorder.

Crowley B, Howe YJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2015 Mar;25(2):183-5. doi: 10.1089/cap.2014.0140. Epub 2015 Mar 6. No abstract available.

PMID:
25746055
49.

Psychopharmacologic treatment of children prenatally exposed to drugs of abuse.

Hulvershorn LA, Schroeder KM, Wink LK, Erickson CA, McDougle CJ.

Hum Psychopharmacol. 2015 May;30(3):164-72. doi: 10.1002/hup.2467. Epub 2015 Mar 3.

50.

A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities.

Zürcher NR, Bhanot A, McDougle CJ, Hooker JM.

Neurosci Biobehav Rev. 2015 May;52:56-73. doi: 10.1016/j.neubiorev.2015.02.002. Epub 2015 Feb 12. Review.

PMID:
25684726

Supplemental Content

Loading ...
Support Center